Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation


Phase N/A Results N/A

Summary of Purpose

To describe the treatment perception from patients with non-valvular atrial fibrillation (NVAF) receiving Pradaxa® or VKA for stroke prevention by using the self-estimation questionnaire of PACT-Q during a 6-month study period.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 March 2018.

20 Jun 2017 13 Jun 2017 9 Aug 2018 29 Mar 2019 1 Mar 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

Not available


  • Boehringer Ingelheim